Related Experiment Video
Updated: May 27, 2026
08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling
1Hinh Ly, Department of Veterinary and Biomedical Sciences, University of Minnesota, Twin Cities, MN 55108, United States.
World Journal of Stem Cells
|November 24, 2011
Summary
Induced pluripotent stem cells (iPSCs) offer therapeutic potential, but their aging markers, like telomere length, require careful study. This review examines how cellular reprogramming affects telomerase function and aging in iPSCs for clinical applications.
Area of Science:
- Stem Cell Biology
- Molecular Biology
- Gerontology
Background:
- Induced pluripotent stem cells (iPSCs) are generated from somatic cells, offering potential for regenerative medicine and disease modeling.
- Cellular aging, indicated by telomere length, is a critical factor that may persist in iPSCs, limiting their therapeutic utility.
- Telomerase, responsible for telomere maintenance, is crucial for cellular longevity, and its dysfunction is linked to diseases like dyskeratosis congenita (DC).
Purpose of the Study:
- To review the impact of cellular reprogramming on telomerase function and telomere length in iPSCs.
- To assess whether iPSCs retain aging markers from their somatic cell origin.
- To discuss the clinical potential and challenges associated with using iPSCs.
Main Methods:
- Review of recent scientific literature on iPSC reprogramming, telomerase activity, and telomere length.
- Analysis of studies involving iPSCs derived from both normal and diseased tissues, including those from patients with dyskeratosis congenita.
- Synthesis of findings related to telomere maintenance and cellular aging in the context of iPSC technology.
Main Results:
- Cellular reprogramming can influence telomerase activity and telomere length in iPSCs, with varying effects depending on the cell source and reprogramming method.
- Evidence suggests that some aging characteristics, including telomere attrition, may be partially reset or altered during reprogramming.
- Understanding these changes is crucial for evaluating the long-term stability and replicative potential of iPSCs.
Conclusions:
- iPSC technology holds promise for disease modeling and therapy, but careful characterization of telomere length and aging markers is essential.
- Further research is needed to optimize reprogramming protocols to ensure the long-term viability and safety of iPSCs for clinical use.
- Addressing the challenges related to cellular aging in iPSCs will be key to unlocking their full therapeutic potential.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...